cytochrome c — LLMpedia

cytochrome c
Vossman · CC BY-SA 3.0 · source
Name	Cytochrome c
Organism	Various eukaryotes and many prokaryotes
Gene	CYCS

Contents

cytochrome c Cytochrome c is a small hemeprotein found in the mitochondrial intermembrane space that participates in electron transport and programmed cell death. Discovered through biochemical work by researchers associated with institutions like Harvard University, Johns Hopkins University, University of Oxford, and Max Planck Society, it became a model protein for studies by scientists such as Linus Pauling, Fred Sanger, Christian B. Anfinsen, and John Kendrew. Its importance spans physiology, evolutionary biology, and biomedical research connected to groups including the National Institutes of Health, Wellcome Trust, and European Molecular Biology Laboratory.

Structure and properties

Cytochrome c is a compact, globular protein of approximately 100 amino acids containing a covalently attached heme group coordinated by histidine and methionine residues; structural insights derived from work at MRC Laboratory of Molecular Biology, Scripps Research, and Rosalind Franklin Institute. High-resolution models solved by techniques developed in laboratories led by Max Perutz, John Cowan, and Richard Henderson revealed a predominately alpha-helical fold stabilized by conserved residues identified in comparative studies involving proteins cataloged at UniProt, Protein Data Bank, and Brookhaven National Laboratory. Biophysical properties such as redox potential, extinction coefficient, and isoelectric point were characterized in experimental programs associated with California Institute of Technology, University of Cambridge, and Massachusetts Institute of Technology. Post-translational modifications and covalent attachments observed in organisms from Saccharomyces cerevisiae to Homo sapiens influence stability and membrane interactions explored in collaborations with groups at ETH Zurich and Karolinska Institutet.

Functionally, this hemeprotein shuttles electrons between complexes within the mitochondrial respiratory chain, a process central to oxidative phosphorylation described by researchers at Columbia University, University of Chicago, and Tokyo Institute of Technology. Beyond bioenergetics, it participates in redox signaling pathways investigated by teams at Stanford University, Yale University, and University of California, San Francisco. In photosynthetic bacteria and mitochondria-related lineages studied by scientists from University of California, Berkeley and Max Planck Institute for Biochemistry, analogous proteins perform electron transfer roles in varied metabolic contexts. Its conserved presence across taxa has made it a marker in phylogenetic analyses conducted by labs at Smithsonian Institution, Natural History Museum, London, and Chinese Academy of Sciences.

Electron transfer by the protein occurs via reversible oxidation and reduction of the heme iron, mediating electron flow between complex III (cytochrome bc1 complex) and complex IV (cytochrome c oxidase) in mitochondria; mechanistic frameworks were refined in studies from University of California, San Diego, Princeton University, and Weizmann Institute of Science. Kinetic and thermodynamic parameters measured by groups at Argonne National Laboratory, Lawrence Berkeley National Laboratory, and Los Alamos National Laboratory support models invoking electron tunneling, docking interfaces, and transient complex formation with partners such as subunits characterized by researchers at Max Planck Institute for Molecular Physiology and Cold Spring Harbor Laboratory. Structural docking and mutagenesis experiments performed in labs linked to Rice University, University of Toronto, and Seoul National University identified interaction surfaces and binding affinities that control rate constants and pathway efficiency.

Upon mitochondrial outer membrane permeabilization, this hemeprotein can be released into the cytosol where it triggers caspase activation via Apaf-1, a pathway elucidated in pioneering work at Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, and German Cancer Research Center. Studies from Memorial Sloan Kettering Cancer Center, University College London, and Johns Hopkins University School of Medicine detailed its participation in apoptosome assembly and cross-talk with Bcl-2 family proteins characterized by investigators at Cold Spring Harbor Laboratory and Institut Pasteur. Additional non-apoptotic signaling roles involving redox-dependent regulation and nitrosylation were described by teams at Imperial College London, University of Pennsylvania, and University of Melbourne, linking it to pathological processes studied at Mayo Clinic and Cleveland Clinic.

The nuclear gene encoding the protein (e.g., CYCS in mammals) and its regulatory elements were mapped by genomics consortia including Human Genome Project, ENCODE Project Consortium, and sequencing centers at Broad Institute. Comparative genomics and molecular evolution analyses performed at University of California, Davis, Harvard Medical School, and University of Edinburgh demonstrated strong conservation with lineage-specific substitutions that informed phylogenies used by researchers at Smithsonian Institution National Museum of Natural History. Mitochondrial targeting sequences, alternative isoforms, and gene duplication events have been reported in taxa studied by Australian National University, University of São Paulo, and University of Cape Town, while evolutionary rate studies referencing work by Motoo Kimura and Ziheng Yang contextualize its utility as a molecular clock.

Clinically, alterations in levels, mutations, or post-translational states are associated with disorders investigated at National Institutes of Health Clinical Center, Mount Sinai Hospital, and Karolinska University Hospital, including mitochondrial diseases and neurodegeneration studied by teams at University of Toronto Faculty of Medicine and University of California, Los Angeles. Its biochemical properties underpin diagnostic assays and therapeutic research undertaken by biotech firms collaborating with Genentech, Pfizer, and Roche. Laboratory techniques using the protein as a model system informed methods in structural biology and drug discovery at GlaxoSmithKline and academic cores at University of Washington. In forensic and evolutionary studies, sequence comparisons used by institutions such as Smithsonian Institution and Natural History Museum, London aid in species identification and phylogeography.

Category:Proteins